A reproducible, sensitive, and cost-effective spectrofluorimetric method has been developed for quantification of the drug ibrutinib in bulk and in its oral capsule formulation. The method was validated in accordance with the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use guidelines with respect to linearity, accuracy, precision, limit of detection (LOD), limit of quantification (LOQ), and robustness. The method was found to be extremely sensitive, and excellent linearity was noted within the concentration range 0.1–7.5 μg/mL with a correlation coefficient (r2) of 0.9961. The LOD and LOQ values for the proposed method were found to be 0.224 and 0.680 μg/mL, respectively. Excellent recoveries of the drug were observed from the marketed capsule formulation by the proposed method (97.59, 1.42% relative standard deviation).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
E. D. Deeks, Drugs, 77, 225–236 (2017).
S. Molica, E. Matutes, C. Tam, and A. Polliack, Hematol. Oncol., 38, 129–136 (2020).
S. Veeraraghavan, S. Viswanadha, S. Thappali, B. Govindarajulu, S. Vakkalanka, and M. Rangasamy, J. Pharm. Biomed. Anal., 107, 151–158 (2015).
J. J. M. Rood, S. van Hoppe, A. H. Schinkel, J. H. M. Schellens, J. H. Beijnen, and R. W. Sparidans, J. Pharm. Biomed. Anal., 118, 123–131 (2016).
D. Beauvais, J. F. Goossens, E. Boyle, B. Allal, T. Lafont, E. Chatelut, C. Herbaux, F. Morschhauser, S. Genay, P. Odou, and C. Danel, J. Chromatogr. B, 1093, 158–166 (2018).
J. J. M. Rood, P. J. A. Dormans, M. J. van Haren, J. H. M. Schellens, J. H. Beijnen, and R. W. Sparidans, J. Chromatogr. B, 1090, 14–21 (2018).
P. Du, Y. Guan, Z. An, P. Li, and L. Liu, Analyst, 144, 5462–5471 (2019).
T. Yasu, K. Momo, H. Yasui, and S. Kuroda, Biomed. Chromatogr., 33, e4435 (2019).
L.-M. Wei, Z.-X. Xu, P.-F. Lv, Y.-L. Xue, X.-X. Wang, and M. Zhang, Lat. Am. J. Pharm., 35, 130–134 (2016).
N. J. R. Hepsebah and A. A. Kumar, Int. J. Pharmacy Pharm. Sci., 11, 22–26 (2019).
M. Iqbal, F. Shakeel, and T. Anwer, J. AOAC Int., 99, 618–625 (2016).
S. S. Prasad, G. K. Mohan, and A. N. Babu, Anal. Methods, 12, 1434–1445 (2019).
S. Vajjha, V. Bommuluri, C. S. Rumalla, R. Doddipalla, M. Kaliyaperumal, and R.B. Korupolu, J. Pharm. Biomed. Anal., 172, 9–17 (2019).
G. H. Bindu and M. M. Annapurna, Res. J. Pharm. Tech., 11, 4587–4591 (2018).
S. Kapavarapu, R. Golkonda, and R. Chintala, Anal. Chem., 16, 7–19 (2016).
N. Konduru, R. Gundla, N. K. Katari, K. Paidikondala, A. S. Reddy, and V. Jagadabi, Anal. Chem. Lett., 10, 113–136 (2020).
S. Illendula, D. Priyanka, V. Shirisha, K. N. V. Rao, and R. Dutt, Int. J. Pharmacy Biol. Sci., 9, 36–46 (2019).
V. Uppala, N. Divya, E. Charishma, K. Harshavardan, Shyamala, and M. Joginapally, Indo Am. J. Pharm. Sci., 3, 324–330 (2016).
S. Muneer, H. A. Ahad, and C. K. Bonnoth, J. Pharm. Res., 11, 712–718 (2017).
M. Fouad, M. Helvenstein, and B. Blankert, J. Anal. Methods Chem., 2015, Article ID 215128 (2015).
M. R. Reddy, K. Mishra, and R. Suresh, Int. J. Pharm. Res. Health Sci., 6, 2303–2307 (2018).
ICH, Validation of analytical procedures: text and methodology Q2 (R1), Int. Conf. Harmonization, Geneva, Switzerland, 11, 1–13 (2005).
Z. Chen, J. Zhai, X. Liu, S. Mao, L. Zhang, S. Rohani, and J. Lu, J. Chem. Thermodyn., 103, 342–348 (2016).
Author information
Authors and Affiliations
Corresponding author
Additional information
Abstract of article is published in Zhurnal Prikladnoi Spektroskopii, Vol. 89, No. 2, p. 288, March–April, 2022.
Rights and permissions
About this article
Cite this article
Mondal, B., Bali, A. Development and Validation of a Sensitive Spectrofluorimetric Method for the Determination of Ibrutinib. J Appl Spectrosc 89, 364–370 (2022). https://doi.org/10.1007/s10812-022-01367-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10812-022-01367-9